Tag Archives: Asterias Biotherapeutics

Patients with Complete Paralysis Show Additional Recovery of Arm, Hand and Finger Function at 9-months After Treatment with Asterias’ AST-OPC1

Third patient recovers two motor levels; three of six (50%) patients in AIS-A 10 million cell cohort have now recovered two motor levels on at least one side FREMONT, Calif., June 13, 2017 /PRNewswire/ –Asterias Biotherapeutics, Inc. (NYSE MKT: AST), … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged , , | 2 Comments

Paralyzed Man Regains Use of Arms and Hands After Experimental Stem Cell Therapy at Keck Hospital of USC

PRN Newswire: News provided by Keck Medicine of USC. See the Full Article  LOS ANGELES, Sept. 7, 2016 /PRNewswire/ — Keck Medical Center of USC today announced that a team of doctors became the first in California to inject … Continue reading

Posted in Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged , , | 2 Comments

Long-Term Studies Reveal Positive Results for Initial Phase of SCI Clinical Trial of Regenerative Medicine-Based Treatment

June 9th, Shepherd Center Atlanta Georgia Asterias Biotherapeutics Inc., a California-based biotechnology company focused on regenerative medicine, recently announced positive results from long-term follow-up studies of five patients – including two treated at Shepherd Center – with thoracic-level spinal cord … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

Spinal Cord Injury and a CIRM-Funded Stem Cell-Based Trial

Spinal Cord Injury and a CIRM-Funded Stem Cell-Based Trial Jane Lebkowski, Asterias Biotherapeutics’ VP of R&D, spoke to CIRM’s governing Board about the company’s CIRM-funded clinical trial for spinal cord injury. Richard Lajara, the fourth participant in a previous trial, … Continue reading

Posted in Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

Early Phase Clinical Trials of Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells (AST-OPC1) in Patients with Subacute SCI

Extensive preclinical testing of AST-OPC1 (formerly GRNOPC1) in animal models of traumatic SCI demonstrated that these cells survive, migrate throughout the injury site, and improve locomotor function. Therefore, a phase 1 clinical trial was initiated to assess the safety of … Continue reading

Posted in Regenerative Medicine, Spinal Research, Stem Cell Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium | Tagged ,

Asterias Biotherapeutics begins Phase 1-2a for acute SCI with OPC1

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, announced today that Atlanta-based Shepherd Center, one of the nation’s top rehabilitation hospitals for spinal cord injury and brain injury, has commenced enrollment … Continue reading

Posted in Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

Alliance for Regenerative Medicine: Stem Cells 2014

Presented by: Teresa Leezer, CEO RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged , , , ,

Spinal Cord Injury and Stem Cell Trials: What is the latest?

California Stem Cell Agency is holding a live “Google Hangout” on Tuesday November 18th, 2014 from Noon to 1PM (Pacific Time). Guests will be Jane Lebkowski from Asterias Biotherapeutics, Roman Reed from the Roman Reed Foundation and Kevin Whittlesey from … Continue reading

Posted in Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged , ,

Asterias Biotherapeutics awarded 14.3 million to test OPC on Spinal Cord Injury

A promising treatment for patients with spinal cord injuries was approved today by the California Institute for Regenerative Medicine (CIRM). The spinal cord therapy will test a type of cell found in the CNS (central nervous system) to see if … Continue reading

Posted in Regenerative Medicine, Stem Cell Research | Tagged , ,